Personal information

Other IDs

Scopus Author ID: 56808706700

Keywords

Cancer stem cells, immunotherapy, dendritic cells, vaccine, cancer, liver fibrosis, Biochemistry

Countries

Egypt

Activities

Collapse all

Employment (3)

Tanta University Faculty of Pharmacy: Tanta, EG

Lecturer (Biochemistry)
Employment
Source: Self-asserted source
Amera Ibrahim

Tanta University Faculty of Pharmacy: Tanta, EG

2014 to 2019 | Assistant Lecturer (Biochemistry)
Employment
Source: Self-asserted source
Amera Ibrahim

Tanta University Faculty of Pharmacy: Tanta, EG

2008 to 2014 | Demonstrator (Biochemistry)
Employment
Source: Self-asserted source
Amera Ibrahim

Education and qualifications (2)

Tanta University Faculty of Pharmacy: Tanta, EG

2015 to 2019 | PhD (Biochemistry)
Education
Source: Self-asserted source
Amera Ibrahim

Tanta University Faculty of Pharmacy: Tanta, EG

2009 to 2014 | M.Sc (Biochemistry)
Education
Source: Self-asserted source
Amera Ibrahim

Works (8)

Competing endogenous RNAs network and therapeutic implications: New horizons in disease research

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
2025-03 | Journal article
DOI: 10.1016/j.bbagrm.2024.195073
Contributors: Nahla E. El-Ashmawy; Eman G. Khedr; Renad T. Darwish; Amera O. Ibrahim
Source: check_circle
Crossref

Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1

Frontiers in Pharmacology
2023 | Journal article
DOI: 10.3389/fphar.2023.1166653
EID:

2-s2.0-85152668025

Part of ISSN: 16639812
Contributors: Abo-Saif, M.A.; Ragab, A.E.; Ibrahim, A.O.; Abdelzaher, O.F.; Mehanyd, A.B.M.; Saber-Ayad, M.; El-Feky, O.A.
Source: Self-asserted source
Amera Ibrahim via Scopus - Elsevier
grade
Preferred source (of 2)‎

Hemin versus erythropoietin: Possible role in Nrf2/HO-1 signaling pathway in rats with nephrotoxicity

Biomedicine and Pharmacotherapy
2022 | Journal article
DOI: 10.1016/j.biopha.2022.113971
EID:

2-s2.0-85141711397

Part of ISSN: 19506007 07533322
Contributors: El-Ashmawy, N.E.; Al-Ashmawy, G.M.; Farag, A.A.; Ibrahim, A.O.
Source: Self-asserted source
Amera Ibrahim via Scopus - Elsevier
grade
Preferred source (of 2)‎

Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition

Bioorganic Chemistry
2022 | Journal article
DOI: 10.1016/j.bioorg.2022.106126
EID:

2-s2.0-85137691166

Part of ISSN: 10902120 00452068
Contributors: Aboukhatwa, S.M.; Ibrahim, A.O.; Aoyama, H.; Al-Behery, A.S.; Shaldam, M.A.; El-Ashmawy, G.; Tawfik, H.O.
Source: Self-asserted source
Amera Ibrahim via Scopus - Elsevier
grade
Preferred source (of 2)‎

Comparative Efficacy and Safety Study of Darbepoetin Alfa versus Epoetin Alfa in Management of Anemia Associated with ESRD in Egyptian Hemodialysis Patients.

Current drug safety
2021-11-22 | Journal article
DOI: 10.2174/1568009621666211123095129
PMID: 34814819
Source: Self-asserted source
Amera Ibrahim
grade
Preferred source (of 3)‎

Dual-targeted therapeutic strategy combining CSC–DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model

Clinical and Translational Oncology
2020-07-20 | Journal article
DOI: 10.1007/s12094-019-02242-4
Contributors: N. E. El-Ashmawy; M. L. Salem; E. G. Khedr; E. A. El-Zamarany; A. O. Ibrahim
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model

Molecular Immunology
2019-07 | Journal article
DOI: 10.1016/j.molimm.2019.04.001
Part of ISSN: 0161-5890
Source: Self-asserted source
Amera Ibrahim
grade
Preferred source (of 3)‎

Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis

Clinical and Experimental Pharmacology and Physiology
2015-09 | Journal article
DOI: 10.1111/1440-1681.12446
Part of ISSN: 0305-1870
Source: Self-asserted source
Amera Ibrahim
grade
Preferred source (of 3)‎

Peer review (2 reviews for 1 publication/grant)

Review activity for Heliyon. (2)
How many people are using ORCID?